“Formulation and characterization of a novel pH-triggered in-situ gelling ocular system containing Gatifloxacin”, Int Curr Pharm J, vol. 1, no. 3, pp. 43–49, Feb. 2012, doi: 10.3329/icpj.v1i3.9661.